Urol. praxi. 2021;22(1):36-38 | DOI: 10.36290/uro.2020.039

Pharmacotherapy of non malignant pain in urology

MUDr. Marek Hakl, Ph.D.
Centrum léčby bolesti Medicinecare, s. r. o., CHK FN Brno a LF MU, Brno

Chronic pain represents significant society - wide society-economy problem. It is participating at a considerable rate to the disability of population of developed countries and it has got adverse effect on quality of life. Strategy for chronic pain treatment is multimodal: it includes pharmacological and rehabilitation treatment, psychotherapy invasive methods and some other treatment alternatives. Basic treatment strategy is based on WHO three - step analgesic ladder. Basic treatment for chronic pain are nonopiod analgesics, combined in accordance with level of pain with weak or strong opioids.

Keywords: chronic pain, pain strategy, pharmacotherapy.

Received: September 28, 2020; Revised: September 28, 2020; Accepted: September 28, 2020; Prepublished online: September 28, 2020; Published: April 15, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hakl M. Pharmacotherapy of non malignant pain in urology. Urol. praxi. 2021;22(1):36-38. doi: 10.36290/uro.2020.039.
Download citation

References

  1. Breivik H, Collett B, Ventafridda V, et al. Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment. Eur J Pain 2006; 10: 287-333. Go to original source... Go to PubMed...
  2. Müller-Schwefe G. Make a CHANGE: optimising communications and pain management decisions. Curr Med Res Opin 2011; 2: 481-488. Go to original source... Go to PubMed...
  3. Skála B. Doporučené postupy pro farmakoterapii bolesti a jejich dopad v oblasti primární péče. Bolest 2008, 3: 151-155.
  4. Doležal T, Hakl M, Kozák J, et al. Metodické pokyny pro farmakoterapii bolesti. Bolest 2016; (Suppl. 1): 1-21.
  5. Metodické pokyny pro farmakoterapii nenádorové bolesti. Bolest 2016; 19(Suppl. 1): 22-28.
  6. Lejčko J, Kozák J. Použití ovoidů u chronické nenádorové bolesti. In Kozak J, Lejčko J, Vrba I, a kol. Opioidy. Mladá fronta, Praha, 2018: 149-163.




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.